Telemedicine for Pediatric Epilepsy Care: A Nonrandomized, Open-Label, Prospective Noninferiority Clinical Trial at a Single Center

Telemedicine (TM) has demonstrated several advantages in the management of chronic diseases, but evidence in pediatric epilepsy is limited. We compared TM with traditional in-person follow-up for pediatric epilepsy. A single-center, prospective, nonrandomized, open-label, noninferiority clinical study was conducted from May 2022 to April 2023. Group assignment was determined by the consultation modality at enrollment, with crossover permitted. The primary outcome was seizure control at 6 months. Secondary outcomes included antiseizure medication (ASM)–related adverse events, emergency department (ED) visits for epilepsy-related concerns, and medication adherence. The primary analysis was performed on an intention-to-treat basis, with a prespecified noninferiority margin of 0.1. Among 190 patients, 55 received TM and 135 received in-person care. Seizure worsening occurred in 16.4% vs 26.7%, respectively (risk difference −10.3% [95% CI, −22.6% to 2.0%]). ASM-related adverse events and ED visits were comparable. TM consultation may be a feasible, noninferior alternative for selective pediatric epilepsy follow-up. Clinical trial registration: ClinicalTrials.gov, https://clinicaltrials.gov/study/NCT05418257 , NCT05418257.

Authors

Institutions

Publication Details

Journal
Journal of Child Neurology
Published
2026-11-17
DOI
https://doi.org/10.1177/08830738261503366
Primary Topic
Telemedicine and Telehealth Implementation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Telemedicine for Pediatric Epilepsy Care: A Nonrandomized, Open-Label, Prospective Noninferiority Clinical Trial at a Single Center

Boram Park, Sejin Heo, Jeehun Lee, Seung Jin Maeng et al.
1 links
Journal of Child Neurology
Telemedicine and Telehealth Implementation
article

Telemedicine for Pediatric Epilepsy Care: A Nonrandomized, Open-Label, Prospective Noninferiority Clinical Trial at a Single Center

Boram Park, Sejin Heo, Jeehun Lee, Seung Jin Maeng, Meong Hi Son, Joo Young Song, Se Uk Lee, Jiwon Lee, Hyun Ji Kim
article en

Abstract

Telemedicine (TM) has demonstrated several advantages in the management of chronic diseases, but evidence in pediatric epilepsy is limited. We compared TM with traditional in-person follow-up for pediatric epilepsy. A single-center, prospective, nonrandomized, open-label, noninferiority clinical study was conducted from May 2022 to April 2023. Group assignment was determined by the consultation modality at enrollment, with crossover permitted. The primary outcome was seizure control at 6 months. Secondary outcomes included antiseizure medication (ASM)–related adverse events, emergency department (ED) visits for epilepsy-related concerns, and medication adherence. The primary analysis was performed on an intention-to-treat basis, with a prespecified noninferiority margin of 0.1. Among 190 patients, 55 received TM and 135 received in-person care. Seizure worsening occurred in 16.4% vs 26.7%, respectively (risk difference −10.3% [95% CI, −22.6% to 2.0%]). ASM-related adverse events and ED visits were comparable. TM consultation may be a feasible, noninferior alternative for selective pediatric epilepsy follow-up. Clinical trial registration: ClinicalTrials.gov, https://clinicaltrials.gov/study/NCT05418257 , NCT05418257.

Journal of Child Neurology
Inha University (KR), Samsung Medical Center (KR), CHA University (KR), Sungkyunkwan University (KR)
Good health and well-being
Telemedicine and Telehealth Implementation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon